DEL MESE, Paola Enza
 Distribuzione geografica
Continente #
NA - Nord America 154
EU - Europa 123
AS - Asia 57
AF - Africa 2
Totale 336
Nazione #
US - Stati Uniti d'America 152
CN - Cina 26
DE - Germania 24
SG - Singapore 22
SE - Svezia 17
IT - Italia 15
IE - Irlanda 14
UA - Ucraina 14
AT - Austria 12
FI - Finlandia 10
FR - Francia 8
KR - Corea 8
PL - Polonia 4
GB - Regno Unito 3
CA - Canada 2
RU - Federazione Russa 2
SN - Senegal 2
IN - India 1
Totale 336
Città #
Houston 23
Singapore 19
Beijing 18
Chandler 16
Santa Clara 16
Dublin 14
Jacksonville 14
Vienna 12
Torino 9
Dearborn 8
Medford 5
Princeton 5
Columbus 4
Milan 4
Nyköping 4
Villeurbanne 4
Warsaw 4
Wilmington 3
Boston 2
Hefei 2
Kunming 2
Toronto 2
Verona 2
Ann Arbor 1
Boardman 1
Falls Church 1
Jinan 1
Nürnberg 1
Shaoxing 1
Shenyang 1
Springfield 1
St Petersburg 1
Zhengzhou 1
Totale 202
Nome #
Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein 92
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin 82
Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. 64
Role of NMDA receptor in homocysteine-induced activation of Mitogen-Activated Protein Kinase and Phosphatidyl Inositol 3-Kinase pathways in cultured human vascular smooth muscle cells 64
Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress 48
Totale 350
Categoria #
all - tutte 1.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 8 24 7 2 8 0 1 5
2020/202121 3 0 3 1 1 1 1 0 4 5 1 1
2021/202241 0 0 0 1 3 0 3 1 3 4 16 10
2022/202351 5 2 1 1 6 15 7 4 7 0 3 0
2023/202417 1 4 0 2 1 0 0 1 0 1 0 7
2024/202547 0 18 0 6 23 0 0 0 0 0 0 0
Totale 350